KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Return on Sales (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Return on Sales for 17 consecutive years, with 1.04% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 211.0% to 1.04% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29%, a 101.0% increase, with the full-year FY2025 number at 0.29%, up 101.0% from a year prior.
  • Return on Sales was 1.04% for Q4 2025 at Bio-Rad Laboratories, up from 0.52% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 5.26% in Q3 2021 to a low of 4.81% in Q1 2022.
  • A 5-year average of 0.11% and a median of 0.14% in 2025 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: plummeted -615bps in 2022, then skyrocketed 491bps in 2023.
  • Bio-Rad Laboratories' Return on Sales stood at 2.14% in 2021, then skyrocketed by 153bps to 1.13% in 2022, then crashed by -55bps to 0.51% in 2023, then plummeted by -309bps to 1.07% in 2024, then soared by 197bps to 1.04% in 2025.
  • Per Business Quant, the three most recent readings for BIO's Return on Sales are 1.04% (Q4 2025), 0.52% (Q3 2025), and 0.49% (Q2 2025).